Skip to main content

Biolase, Inc

BIOLDelisted Sep 6, 2024
Industry
Dental Equipment & Supplies
SEC CIK
0000811240

Biolase, Inc was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 12, 2023; 29 institutions reported holding it in 13F filings for Q2 2023, worth $311.8K in total; no superinvestor held it.

13F holders, Q4 2023

Institutional positions in Biolase, Inc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

BIOL is no longer listed, and 13F filings after Q2 2023 list far fewer holders. See Q2 2023

Institutional holders
16
+4 vs. Q3 2023
Shares held
298.9K
+191.8K (+179.0%) vs. Q3 2023
Total value
$335.6K
+$136.4K (+68.5%) vs. Q3 2023
New holders
6
4 more added
Sold out
2
2 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BIOL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 16 institutions
Q1 2021: 41 institutionsQ2 2021: 42 institutionsQ3 2021: 47 institutionsQ4 2021: 50 institutionsQ1 2022: 37 institutionsQ2 2022: 25 institutionsQ3 2022: 24 institutionsQ4 2022: 25 institutionsQ1 2023: 27 institutionsQ2 2023: 29 institutionsQ3 2023: 12 institutionsQ4 2023: 16 institutionsQ1 2024: 18 institutionsQ2 2024: 2 institutionsQ3 2024: 1 institutionQ4 2024: 1 institutionQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ4 2023: $335.6K
Q1 2021: $14.8MQ2 2021: $12.4MQ3 2021: $14.4MQ4 2021: $6.85MQ1 2022: $6.17MQ2 2022: $6.34MQ3 2022: $3.58MQ4 2022: $445.8KQ1 2023: $1.49MQ2 2023: $311.8KQ3 2023: $199.2KQ4 2023: $335.6KQ1 2024: $116.1KQ2 2024: $1.94KQ3 2024: $1Q4 2024: $1Q1 2025: $1Q2 2025: $1Q3 2025: $1Q4 2025: $1Q1 2026: $1Q2 2026: $1
Institutions holding BIOL and their total value by quarter
QuarterHoldersValue
Q2 20261$1
Q1 20261$1
Q4 20251$1
Q3 20251$1
Q2 20251$1
Q1 20251$1
Q4 20241$1
Q3 20241$1
Q2 20242$1.94K
Q1 202418$116.1K
Q4 202316$335.6K
Q3 202312$199.2K
Q2 202329$311.8K
Q1 202327$1.49M
Q4 202225$445.8K
Q3 202224$3.58M
Q2 202225$6.34M
Q1 202237$6.17M
Q4 202150$6.85M
Q3 202147$14.4M
Q2 202142$12.4M
Q1 202141$14.8M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Biolase, Inc; share changes are against Q3 2023.

Institutions holding BIOL in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Anson Funds Management LP185,127$207.7K0.04%+133,846+261.0%Added
BlackRock Inc.25,018$28.1K0.00%00.0%Unchanged
Kellett Schaffner Wealth Advisors LLC19,060$21.4K0.02%+19,060New
Citadel Advisors LLC13,818$15.5K0.00%+13,818New
Zhang Financial LLC13,770$15.4K0.00%+1,692+14.0%Added
Virtu Financial LLC12,289$14.0K0.00%+12,289New
Vanguard Group Inc10,911$12.2K0.00%+10,911New
Two Sigma Investments, LP10,726$12.0K0.00%+10,726New
UBS Group AG5,615$6.30K0.00%+5,615New
Tower Research Capital LLC (TRC)2,447$2.75K0.00%+833+51.6%Added
Advisor Group Holdings, Inc.50$560.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec37$420.00%00.0%Unchanged
Bank of America Corp23$260.00%−18−43.9%Reduced
Wells Fargo & Company18$200.00%+10+125.0%Added
Morgan Stanley14$160.00%−3−17.6%Reduced
Huntington National Bank1$10.00%00.0%Unchanged
Walleye Capital LLC0$00.00%−16,934−100.0%Sold out
IFP Advisors, Inc0$00.00%−81−100.0%Sold out